Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0000897069-25-001795

10% owner sold 6,612 shares at an average $8.25 ($54,575)

  • 10% owner acquired 395 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cambrian BioPharma Inc 10% owner 2025-12-09 Sale −3,105 $8.59 $26,672 158,254 D
Cambrian BioPharma Inc 10% owner 2025-12-09 Sale −2,666 $7.95 $21,195 155,588 D
Cambrian BioPharma Inc 10% owner 2025-12-09 Option exercise +395 $6.40 $2,528 155,983 D
Cambrian BioPharma Inc 10% owner 2025-12-09 Sale −395 $8.04 $3,176 155,588 D
Cambrian BioPharma Inc 10% owner 2025-12-09 Sale −446 $7.92 $3,532 155,142 D
Derivatives
Cambrian BioPharma Inc 10% owner 2025-12-09 Option exercise · Stock Option (Right to Buy) −395 0 D
Open-market sales · 6,612 sh · avg $8.25 · $54,575
Loading xslF345X05/form4.xml…